Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Androgen Insensitivity Syndrome

fluorodeoxyglucose f18 has been researched along with Androgen Insensitivity Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, EJ; Lee, J; O, JH; Park, G1
Bilgiç, R; Mert, M; Ozekici, U; Ozpaçaci, T; Ozülker, F; Ozülker, T1
Nguyen, BD1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Androgen Insensitivity Syndrome

ArticleYear
FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:8

    Topics: Androgen-Insensitivity Syndrome; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Seminoma; Testicular Neoplasms; Young Adult

2017
Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome.
    Annals of nuclear medicine, 2010, Volume: 24, Issue:1

    Topics: Adult; Androgen-Insensitivity Syndrome; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Sertoli-Leydig Cell Tumor; Tomography, X-Ray Computed

2010
PET imaging of Sertoli cell tumor in androgen insensitivity syndrome.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:9

    Topics: Aged; Androgen-Insensitivity Syndrome; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, Emission-Computed

2003